1. Home
  2. AVDL vs FIGS Comparison

AVDL vs FIGS Comparison

Compare AVDL & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • FIGS
  • Stock Information
  • Founded
  • AVDL 2015
  • FIGS 2013
  • Country
  • AVDL Ireland
  • FIGS United States
  • Employees
  • AVDL N/A
  • FIGS N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • FIGS Apparel
  • Sector
  • AVDL Health Care
  • FIGS Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • FIGS Nasdaq
  • Market Cap
  • AVDL 784.6M
  • FIGS 694.0M
  • IPO Year
  • AVDL 1996
  • FIGS 2021
  • Fundamental
  • Price
  • AVDL $9.11
  • FIGS $4.36
  • Analyst Decision
  • AVDL Strong Buy
  • FIGS Sell
  • Analyst Count
  • AVDL 6
  • FIGS 4
  • Target Price
  • AVDL $18.17
  • FIGS $4.50
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • FIGS 2.1M
  • Earning Date
  • AVDL 05-07-2025
  • FIGS 05-08-2025
  • Dividend Yield
  • AVDL N/A
  • FIGS N/A
  • EPS Growth
  • AVDL N/A
  • FIGS N/A
  • EPS
  • AVDL N/A
  • FIGS 0.01
  • Revenue
  • AVDL $194,450,000.00
  • FIGS $561,166,000.00
  • Revenue This Year
  • AVDL $55.11
  • FIGS $0.65
  • Revenue Next Year
  • AVDL $30.13
  • FIGS $3.26
  • P/E Ratio
  • AVDL N/A
  • FIGS $597.72
  • Revenue Growth
  • AVDL 252.64
  • FIGS 3.02
  • 52 Week Low
  • AVDL $6.38
  • FIGS $3.57
  • 52 Week High
  • AVDL $17.30
  • FIGS $7.06
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 53.96
  • FIGS 46.03
  • Support Level
  • AVDL $8.77
  • FIGS $4.36
  • Resistance Level
  • AVDL $9.31
  • FIGS $4.66
  • Average True Range (ATR)
  • AVDL 0.41
  • FIGS 0.20
  • MACD
  • AVDL -0.04
  • FIGS -0.04
  • Stochastic Oscillator
  • AVDL 53.60
  • FIGS 6.01

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.

Share on Social Networks: